EBA
PRAX icon

Eagle Bay Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Eagle Bay Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Buy
+956
New +$303K 0.24% 91

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Eagle Bay Advisors's PRAX Position: Q2 2026 in Review

Eagle Bay Advisors opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 956 shares worth $320K. The stake represents 0.24% of the portfolio and ranks #91 among its holdings.

309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Eagle Bay Advisors held 956 shares of Praxis Precision Medicines worth $320K as of Q2 2026.
  • Praxis Precision Medicines was a new Eagle Bay Advisors position in Q2 2026.
  • Praxis Precision Medicines made up 0.24% of Eagle Bay Advisors's portfolio in Q2 2026, its #91 holding.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Eagle Bay Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.